Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod

Cindy Berthelot, Mary C. Dickerson, Peter Rady, Qin He, Farhad Niroomand, Stephen K. Tyring, Amit G. Pandya

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

Epidermodysplasia verruciformis (EV) is a rare disorder characterized by widespread human papillomavirus infection and malignant transformation. EV may be caused by mutations of the genes EVER1 or EVER2, which are located on the EV1 locus, 17q25. We describe a patient with EV and a novel homozygous gene mutation of EVER2 gene who was treated successfully with topical imiquimod.

Original languageEnglish (US)
Pages (from-to)882-886
Number of pages5
JournalJournal of the American Academy of Dermatology
Volume56
Issue number5
DOIs
StatePublished - May 1 2007

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod'. Together they form a unique fingerprint.

Cite this